MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | -0.82 | -1.04 | -0.93 | -4.49 | -1.24 |
| Net cashflow-operating activity | -0.63 | -0.87 | -4.34 | -0.93 | -0.49 |
| Net cash used in investing activity | 0.12 | -0.10 | 0.46 | 1.54 | 0.46 |
| Netcash used in fin. activity | 0.51 | 0.96 | 3.88 | -0.61 | 0.03 |
| Net inc/dec in cash and equivlnt | - | -0.01 | - | - | - |
| Cash and equivalnt begin of year | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Cash and equivalnt end of year | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis